The Europe Laboratoray Centrifuges Market was valued at $95.31 Million in 2025 and projected to reach to $107.08 Million by 2030, representing a compound annual growth rate of 2.0%. Europe's laboratory centrifuges market is poised for steady growth through 2030, driven by the region's advanced healthcare infrastructure and sustained investment in diagnostic capabilities.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Europe's laboratory centrifuges market is valued at $95.31 million in 2025, with a projected growth to $107.08 million by 2030, representing a steady 2.0% CAGR.
Europe maintains a mature and well-established laboratory centrifuges market, supported by strong healthcare infrastructure and continuous investment in diagnostic and research capabilities across the region.
Germany leads the European market with $156.9 million, followed by the UK at $133.8 million and France at $74.7 million, reflecting robust healthcare and research sectors.
Europe's 2.0% CAGR reflects conservative but consistent market expansion, driven by aging populations, increased diagnostic demand, and modernization of laboratory facilities across member states.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | AUTOMATED CENTRIFUGES (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 2.8% from 2025 to 2030 |
| Largest Segment | EQUIPMENT (Product) |
| Market Size Base Year (Billions) | ~USD 1.62 (2025) |
| Revenue Forecast (Billions) | ~USD 1.86 (2030) |
| Segments Covered | Product, Type, Platform Type, Rotor Type, Usage Type, Application, End User |
7 segment dimensions are covered across the global market.
| Segment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 70.76 | 71.64 | 72.75 | 74.24 | 75.89 | 77.81 | 79.93 | 82.27 | 2.3 |
| BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES | 140.51 | 142.69 | 145.34 | 148.76 | 152.56 | 156.91 | 161.7 | 166.96 | 2.7 |
| HOSPITALS | 180 | 182.55 | 185.7 | 189.82 | 194.43 | 199.73 | 205.57 | 212.01 | 2.5 |
| OTHER END USERS | 18.97 | 18.89 | 18.86 | 18.9 | 18.98 | 19.1 | 19.25 | 19.42 | 0.5 |
| TOTAL | 410.24 | 415.78 | 422.64 | 431.72 | 441.85 | 453.55 | 466.45 | 480.66 | 2.4 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| GEA GROUP | United States | Public Company | Equipment – Microcentrifuge,Equipment – Ultracentrifuge,Accessories – Tubes, |
| BECKMAN COULTER | United States | Private Company | Equipment – Microcentrifuge,Equipment – Ultracentrifuge,Equipment – Other Clinical Benchtop Centrifuges, |
| FLUOR CORPORATION | United States | Public Company | Centrifuge Equipment (Microcentrifuge, Ultracentrifuge) – EPC integration and facility design,Centrifuge Accessories (Tube, Plate) – logistics and lab fit-out services,Benchtop Platform – clinical diagnostics labs in hospitals, |
| THERMO FISHER SCIENTIFIC INC. | United States | Public Company | Equipment – Microcentrifuge,Equipment – Ultracentrifuge,Accessories – Tubes, |
| DANAHER | United States | Public Company | Equipment – Benchtop Microcentrifuges (Clinical Diagnostics in Hospitals),Equipment – Benchtop Ultracentrifuges (Clinical/Advanced Diagnostics in Hospitals),Accessories – Tubes, |
| EPPENDORF | Germany | Private Company | Equipment – Microcentrifuge,Equipment – Ultracentrifuge,Accessories – Tubes, |
| QIAGEN N.V. | Netherlands | Public Company | Equipment – Microcentrifuge (Benchtop, Clinical Diagnostics, Hospitals),Equipment – Ultracentrifuge,Accessories – Tubes, |
| SARTORIUS AG | United States | Public Company | Equipment - Microcentrifuge,Equipment - Ultracentrifuge,Accessories - Tubes, |
| BIO-RAD | United States | Public Company | Equipment – Microcentrifuge,Equipment – Ultracentrifuge,Accessories – Tubes, |
| AGILENT TECHNOLOGIES, INC. | United States | Public Company | Equipment – Microcentrifuge (Benchtop, clinical diagnostics use in hospitals),Equipment – Ultracentrifuge (specialized clinical and translational diagnostics workflows),Accessories – Tubes, |
| HAIER BIOMEDICAL | China | Public Company | Benchtop clinical centrifuge equipment (swinging-bucket, diagnostics, hospitals),Microcentrifuges and ultracentrifuges (equipment),Centrifuge accessories (tubes, plates, rotors, consumables), |
GEA GROUP is a publicly traded German-American industrial equipment manufacturer founded in 1881 with 19,670 employees. The company specializes in process technology and components for various industries including food, beverage, and pharmaceuticals.
Beckman Coulter is a privately held United States company founded in 1935 with 11,900 employees. The company manufactures and distributes life science and diagnostic instruments and reagents.
Fluor Corporation is a publicly traded engineering and construction company founded in 1912 with 22,995 employees. The company provides services across energy, chemicals, infrastructure, and government sectors.
Thermo Fisher Scientific Inc. is a publicly traded life sciences company founded in 1956 with 125,000 employees. The company provides laboratory equipment, reagents, software, and services for research, diagnostics, and bioproduction.
Danaher is a publicly traded diversified conglomerate founded in 1969 with 59,000 employees. The company operates across life sciences, diagnostics, environmental and applied solutions, and product identification segments.
Eppendorf is a privately held German laboratory equipment manufacturer founded in 1945 with 4,358 employees. The company produces centrifuges, pipettes, and other instruments for life science research and diagnostics.
QIAGEN N.V. is a publicly traded Dutch molecular diagnostics company founded in 1984 with 5,500 employees. The company develops and manufactures sample preparation and molecular testing technologies.
Sartorius AG is a publicly traded German life sciences company founded in 1870 with 14,242 employees. The company provides laboratory and bioprocess equipment, including centrifuges and filtration systems.
Bio-Rad is a publicly traded life sciences company founded in 1952 with 7,450 employees. The company manufactures and distributes reagents, instruments, and software for research and diagnostics.
Agilent Technologies, Inc. is a publicly traded United States company founded in 1999 with 18,000 employees. The company provides analytical instruments, software, and services for life sciences, diagnostics, and applied markets.
Haier Biomedical is a publicly traded Chinese company founded in 2005 with 2,945 employees. The company manufactures biomedical refrigeration and laboratory equipment.
| Country | 2025 size (native) |
|---|---|
| Germany | USD 156.9 Million |
| UK | USD 133.8 Million |
| France | USD 74.7 Million |
| Italy | USD 46.3 Million |
| Spain | USD 38.5 Million |
| Rest Of Europe | USD 30.4 Million |
Europe's laboratoray centrifuges market is valued at $95.31 million in 2025, representing a mature segment within the broader European healthcare equipment industry.
Europe's laboratoray centrifuges market is forecast to reach $107.08 million by 2030, reflecting steady expansion over the five-year period.
Europe's laboratoray centrifuges market is expected to grow at a compound annual growth rate of 2.0% from 2025 to 2030.
Europe's market growth is driven by modernization of laboratory facilities, pharmaceutical research expansion, biotechnology innovation, and compliance with stringent regulatory standards.
Europe's 2.0% CAGR reflects a mature, saturated market with established laboratory infrastructure, whereas emerging regions experience higher growth rates from initial market development.
The study involved four main activities to determine the current size of the laboratory centrifuges market. Comprehensive secondary research was conducted to gather information on the market and its various subsegments. The next step was to confirm these findings, assumptions, and size estimates with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were used to calculate the global market size. Afterwards, market segmentation and data triangulation methods were applied to estimate the size of segments and subsegments.
Secondary research sources included directories, Factiva, white papers, Bloomberg Business, annual reports, SEC filings, business filings, and investor presentations. These sources offered valuable insights into market leaders, sector divisions, and technological differences within various segments of the laboratory centrifuges market.
Several stakeholders, including manufacturers of laboratory centrifuge products, vendors, distributors, and technologists from hospitals and clinics, were consulted for this report. The demand side of this market is characterized by increasing R&D investments and research grants, technological advancements and innovative rotor designs, the rising prevalence of infectious diseases leading to higher volumes of sample testing and cell-based research in laboratory centrifuges, and expanding applications of laboratory centrifuges. Various primary sources from both the supply and demand sides of the market were interviewed to gather qualitative and quantitative information.
A breakdown of the primary respondents is provided below.
Note q: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 2: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 1 billion, Tier 2 = < USD 500 million, and Tier 3 = < USD 100 million.
To know about the assumptions considered for the study, download the pdf brochure
Both top-down and bottom-up approaches were used to estimate and validate the total size of the laboratory centrifuges market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
This report utilized the revenue share analysis of major companies to evaluate the size of the global laboratory centrifuges market. This analysis involved identifying key market participants and calculating their revenue from laboratory centrifuges using a variety of data.

To ensure precise data, the laboratory centrifuges market was segmented into various parts and subparts. A data triangulation method using both top-down and bottom-up approaches was employed. This involved examining factors and trends from both the demand and supply sides to confirm the findings for each segment. Combining this segmentation with the triangulation method helps make sure that the market data is both accurate and trustworthy.
A laboratory centrifuge is a motor-powered device used in labs to quickly spin liquid samples, applying centrifugal force to separate components based on their density. Its primary purpose is to speed up the sedimentation of suspended particles—such as cells, blood components, organelles, or macromolecules—inside a tube or container. Laboratory centrifuges are essential in diagnostics, biomedical research, pharmaceutical development, and industrial labs, allowing efficient separation, purification, and preparation of biological and chemical samples for further analysis or processing.
Full forecast, segment splits, and company analysis for all Laboratoray Centrifuges Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report